Zensun (China)

Recent papers from Zensun (China)

1. A Phase II, Randomized, Double-Blind, Multicenter, Based on Standard Therapy, Placebo-Controlled Study of the Efficacy and Safety of Recombinant Human Neuregulin-1 in Patients With Chronic Heart FailureJournal of the American College of Cardiology · 2010
2. Neuregulin-1/erbB-Activation Improves Cardiac Function and Survival in Models of Ischemic, Dilated, and Viral CardiomyopathyJournal of the American College of Cardiology · 2006
3. Safety, Tolerability, and Pharmacokinetics of Recombinant Human Neuregulin-1 in Healthy Chinese SubjectsAmerican Journal of Cardiovascular Drugs · 2023
4. Neuregulin 1 treatment improves glucose tolerance in diabetic db/db mice, but not in healthy miceArchives of Physiology and Biochemistry · 2018
5. Neuregulin 1 improves complex 2-mediated mitochondrial respiration in skeletal muscle of healthy and diabetic miceScientific Reports · 2017
6. Neuregulin 1 Sustains the Gene Regulatory Network in Both Trabecular and Nontrabecular MyocardiumCirculation Research · 2010
7. Cardiac functional improvement in rats with myocardial infarction by up-regulating cardiac myosin light chain kinase with neuregulinCardiovascular Research · 2010